We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$1.02B
AUM Growth
+$269M
Cap. Flow
+$29.8M
Cap. Flow %
2.93%
Top 10 Hldgs %
44.41%
Holding
92
New
31
Increased
16
Reduced
12
Closed
24

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$36.6M
2
BABA icon
Alibaba
BABA
+$25.9M
3
ZBRA icon
Zebra Technologies
ZBRA
+$24.4M
4
ARMK icon
Aramark
ARMK
+$21.1M
5
COTY icon
Coty
COTY
+$20.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$24M
2
SGI
Somnigroup International
SGI
+$20.4M
3
KEYS icon
Keysight
KEYS
+$20.2M
4
RCL icon
Royal Caribbean
RCL
+$17.4M
5
RH icon
RH
RH
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Miscellaneous 24.67%
3 Industrials 11.95%
4 Technology 10.39%
5 Consumer Discretionary 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$80.8B
$135M 13.22%
+865,000
New +$133M
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$489B
$48.6M 4.77%
+260,000
New +$47.9M
BHVN
3
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$43.9M 4.31%
1,001,410
+157,144
+19% +$8.86M
MSFT icon
4
Microsoft
MSFT
$3.81T
$38.7M 3.8%
288,567
+18,500
+7% +$2.35M
FCX icon
5
Freeport-McMoran
FCX
$110B
$36.5M 3.58%
+3,140,882
New +$36.6M
XBI icon
6
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$35.1M 3.45%
+400,000
New +$34.1M
CZR icon
7
Caesars Entertainment
CZR
$6.06B
$33.6M 3.31%
730,401
+132,234
+22% +$6.48M
ARGX icon
8
argenx
ARGX
$64B
$29.8M 2.93%
210,372
-60,176
-22% -$7.64M
AMZN icon
9
Amazon
AMZN
$2.87T
$25.8M 2.54%
272,840
+3,380
+1% +$315K
BABA icon
10
Alibaba
BABA
$296B
$25.4M 2.5%
+150,000
New +$25.9M
ZBRA icon
11
Zebra Technologies
ZBRA
$16.9B
$25.4M 2.49%
+121,047
New +$24.4M
ARMK icon
12
Aramark
ARMK
$15.3B
$23.5M 2.31%
+902,328
New +$21.1M
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.24T
$23.1M 2.27%
426,040
-164,880
-28% -$9.54M
BSX icon
14
Boston Scientific
BSX
$67.9B
$22.9M 2.25%
531,813
-30,828
-5% -$1.19M
COTY icon
15
Coty
COTY
$2.51B
$22.2M 2.18%
+1,653,061
New +$20.3M
CSTM icon
16
Constellium
CSTM
$3.66B
$20.8M 2.04%
2,069,219
+1,214
+0.1% +$11.2K
MIDD icon
17
Middleby
MIDD
$5.1B
$20.7M 2.03%
152,259
-110,222
-42% -$14.8M
NSC icon
18
Norfolk Southern
NSC
$78.3B
$19.8M 1.95%
99,531
-52,449
-35% -$10.4M
CP icon
19
Canadian Pacific Kansas City
CP
$82.7B
$19.2M 1.89%
407,870
-119,735
-23% -$5.35M
BA icon
20
Boeing
BA
$166B
$18.5M 1.82%
+50,890
New +$18.6M
HUYA
21
Huya Inc
HUYA
$498M
$16.2M 1.59%
+655,282
New +$15.1M
HRTX icon
22
Heron Therapeutics
HRTX
$62M
$15.4M 1.52%
830,821
-257,345
-24% -$5.14M
PFE icon
23
PUT
Pfizer
PFE
$159B
$13.7M 1.34%
+332,432
New +$13.2M
UNH icon
24
UnitedHealth
UNH
$353B
$13.5M 1.33%
+55,312
New +$13.3M
DIS icon
25
Walt Disney
DIS
$187B
$13.4M 1.32%
+95,823
New +$12.7M
1
2 3 4

Similar funds

PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
ACM
Arini Captial Management London, United Kingdom $975M AUM
FM
Family Management New York $975M AUM 23.16% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $979M AUM 50.58% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
ZI
ZEGA Investments Palm Beach Gardens, Florida $973M AUM 27.27% 1-Year Est. Return
RIA
RPG Investment Advisory Pleasanton, California $973M AUM 39.93% 1-Year Est. Return

Kingdon Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Kingdon Capital Management held 92 positions worth $1.02B, up 36% from $748M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Kingdon Capital Management's Q2 2019 filing shows 31 new, 16 increased, 12 reduced and 24 closed positions. Its largest new stake was Freeport-McMoran: 3,140,882 shares worth $36.5M. The largest sale was Celgene Corp, an estimated $24M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Miscellaneous and Industrials.

  • Kingdon Capital Management's largest Q2 2019 buy was Freeport-McMoran: 3,140,882 shares worth $36.5M.
  • Kingdon Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019, an estimated $8.86M increase.
  • Kingdon Capital Management's biggest Q2 2019 reduction was Royal Caribbean, cutting an estimated $17.4M.
  • Kingdon Capital Management fully exited Celgene Corp in Q2 2019, selling an estimated $24M.
  • Kingdon Capital Management's ten largest holdings make up 44% of its $1.02B portfolio in Q2 2019.
  • Kingdon Capital Management opened 31 new positions and closed 24 in Q2 2019.
  • Kingdon Capital Management's portfolio value rose 36% quarter-over-quarter to $1.02B.

Based on Kingdon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.